| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/01/2007 | US20070050868 Agents for phytoremediation |
| 03/01/2007 | US20070050867 Methods of modulating cytokinin related processes in a plant using B3 domain proteins |
| 03/01/2007 | US20070050866 Control of hypocotyllength and flowering time by COL8 gene |
| 03/01/2007 | US20070050859 Selecting a codon of a parent polynucleotide that encodes a polypeptide for replacement with a synonymous codon, replacing the codon with synonymous codon (corresponds to an iso-tRNA ) to form a synthetic polynucleotide and introducing into a mammal cell |
| 03/01/2007 | US20070050856 Use of protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 03/01/2007 | US20070050855 Immunoglobulin fusion comprising blood glycoprotein with reduced glycosylation for use in prevention and treatment of septic shock, cachexia, viral and parasitic infection, autoimmune, arthritic and/or graft rejection |
| 03/01/2007 | US20070049743 Novel nucleic acids and polypeptides |
| 03/01/2007 | US20070049740 Mammalian transforming growth factor beta-9 |
| 03/01/2007 | US20070049739 Method and system for extracting blood-derived growth factors |
| 03/01/2007 | US20070049738 amino acid sequences covalent attached to retroviruses or to leukemia virus transmembrane glycoproteins; phage display libraries; drug targets |
| 03/01/2007 | US20070049737 Homogeneous preparations of il-28 and il-29 |
| 03/01/2007 | US20070049736 Cytokine receptor specific immunoglobulin for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/01/2007 | US20070049732 Ultra-high yield intravenous immune globulin preparation |
| 03/01/2007 | US20070049731 Rapid Isolation of Osteoinductive Protein Mixtures from Mammalian Bone Tissue |
| 03/01/2007 | US20070049730 for treatment of disorders which are mediated at least in part by Hedgehog (Hh) especially Desert hedgehog (Dhh) in particular testicular cancer |
| 03/01/2007 | US20070049729 Interleukin-17 receptor homologue |
| 03/01/2007 | US20070049549 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070049548 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070049533 Analogs of peptides corresponding to class I major histocompatibility complex (MHC)-restricted T-cell epitopes that contain amino acid substitutions of norleucine and/or norvaline; intranodal administration a an immunopotentiating agent |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070049531 GLP-1 agonist and cardiovascular complations |
| 03/01/2007 | US20070049530 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070049529 Reducing the growth of cancer cells in a mammal by administering polypeptide of the invention; |
| 03/01/2007 | US20070049528 Nucleotide sequence coding polypeptide for use in the treatment cell proliferative disorders; detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo |
| 03/01/2007 | US20070049527 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment |
| 03/01/2007 | US20070049526 using Zven1 and Zven2 polypeptides to increase chemokine production for treating intestinal motility disorders and improving gastrointestinal funciton |
| 03/01/2007 | US20070049525 Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammation |
| 03/01/2007 | US20070049522 Perioperative injection of a polypeptide preferential inhibitor of kallikrein, rather than aprotinin, for cardiopulmonary bypass surgery or coronary artery bypass grafting |
| 03/01/2007 | US20070049516 Use of Insulin for the Treatment of Cartilaginous Disorders |
| 03/01/2007 | US20070048862 Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines |
| 03/01/2007 | US20070048861 plasmid constructs useful for the delivery of DNA vaccines; having a transcription cassette capable of directing the expression of a vaccine nucleic acid insert encoding immunogens derived from any pathogen, including fungi, bacteria and viruses |
| 03/01/2007 | US20070048847 Methods of producing antibodies to cytokine receptor |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048845 Cytokine zalpha11 ligand fusion proteins |
| 03/01/2007 | US20070048844 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 03/01/2007 | US20070048843 Homogeneous preparations of IL-28 and IL-29 |
| 03/01/2007 | US20070048842 using an E. coli expression system for the large scale production of IL-21 to a level of greater than 1 g/L in fed batch fermentation |
| 03/01/2007 | US20070048841 Viricidal polypeptide for prevention and treatment of hepatitis infection |
| 03/01/2007 | US20070048840 Human Zven polynucleotides |
| 03/01/2007 | US20070048837 Site specific protein modification |
| 03/01/2007 | US20070048836 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 03/01/2007 | US20070048835 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048834 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048833 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048832 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048831 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048830 Polynucleotide that encodes a protein composed of a first polypeptide disulfide-bonded to a second polypeptide that stimulates proliferation, differentiation, or migration of mesenchymal cells; monoclonal and single-chain antibodies; activating a cell-surface platelet-derived growth factor receptor |
| 03/01/2007 | US20070048829 polynucleotide that encode polypeptides having mitogenic activity on human aortic smooth muscle cells |
| 03/01/2007 | US20070048828 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals |
| 03/01/2007 | US20070048827 Mammalian transforming growth factor beta-9 |
| 03/01/2007 | US20070048826 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 03/01/2007 | US20070048825 Compositions and methods for the diagnosis and treatment of tumor |
| 03/01/2007 | US20070048824 Interleukin-17 receptor homologue |
| 03/01/2007 | US20070048823 Compositions and Methods for Producing Apolipoprotein Gene Products in Lactic Acid Bacteria |
| 03/01/2007 | US20070048822 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
| 03/01/2007 | US20070048818 Human secreted proteins |
| 03/01/2007 | US20070048817 Synthesiing a cyclic dipeptide (Albonoursin) by transforming a host cell with a vector having a specific sequence and incubating to allow expression of a cyclodipeptide synthase that subsequently catalizes the cyclization of two amino acids |
| 03/01/2007 | US20070048811 Tumor suppressor designated TS10q23.3 |
| 03/01/2007 | US20070048810 ATP-binding cassette protein responsible for cytotoxin resistance |
| 03/01/2007 | US20070048805 Methods of using Zven antibodies |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048798 Expression vector; a prokaryotic origin of replication, a transcriptional initiation DNA element, a polynucleotide sequence, and a transcriptional terminator; optimizing codons and mRNA secondary structure for translation in E. coli; ultrafiltration |
| 03/01/2007 | US20070048794 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 03/01/2007 | US20070048791 CRYSTAL STRUCTURES AND MODELS FOR Fc RECEPTORS AND USES THEREOF IN THE DESIGN OR IDENTIFICATION OF Fc RECEPTOR MODULATOR COMPOUNDS |
| 03/01/2007 | US20070048781 Mammalian cytokines; related reagents and methods |
| 03/01/2007 | US20070048780 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors; kits for diagnosing infection and vaccines |
| 03/01/2007 | US20070048778 determining the amount of a polynucleotide sequence or a fragment of at least 20 consecutive nucleotides in a test sample and comparing the amount with that from a control, wherein an increase indicates a gastrointestinal disorder |
| 03/01/2007 | US20070048775 Evolution of whole cells and organisms by recursive sequence recombination |
| 03/01/2007 | US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/01/2007 | US20070048771 Nucleic acid of given sequence; useful as modulating agents in regulating cellular processes |
| 03/01/2007 | US20070048754 Epidermal growth factor receptor mutations |
| 03/01/2007 | US20070048753 Sodium channel protein type III alpha-subunit splice variant |
| 03/01/2007 | US20070048381 Methods for promoting growth of bone, ligament, and cartilage |
| 03/01/2007 | US20070048333 CD4+ T-lymphocyte-specific Hepatitis C virus-epitopes |
| 03/01/2007 | US20070048330 Optimized multi-epitope constructs and uses thereof |
| 03/01/2007 | US20070048329 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
| 03/01/2007 | US20070048318 Method for treating psoriasis |
| 03/01/2007 | US20070048317 Method of treating fibroproliferative disorders |
| 03/01/2007 | US20070048316 Method of reducing proliferation of cells in a mammal |
| 03/01/2007 | US20070048312 Mixture comprising A beta -derived diffusible ligand (ADDL) specific immunoglobulin which binds soluble amyloid beta protein for use in diagnosis, prevention and treatment of nervous sytem disorders |
| 03/01/2007 | US20070048310 Human ataxin-1-like polypeptide IMX97018 |
| 03/01/2007 | US20070048309 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048308 Nucleic acid encoding cytokine receptor zcytor17 |
| 03/01/2007 | US20070048307 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment |
| 03/01/2007 | US20070048305 CD147 binding molecules as therapeutics |
| 03/01/2007 | US20070048304 Method of treating allergy using antibody against human interleukin-5 receptor alpha chain |
| 03/01/2007 | US20070048303 Nucleic acid encoding cytokine receptor zcytor17 |
| 03/01/2007 | US20070048301 Compositions and methods for the treatment of immune related diseases |
| 03/01/2007 | US20070048299 Methods of inducing an immune response |
| 03/01/2007 | US20070048287 Molecular antigen array |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 03/01/2007 | US20070048283 Exposing to immunogenic portion of protein and/or encoding nucleotide homologenous to sequence 20 or 22b; eliciting response to 74P3B3 protein; pancreatic cancer |
| 03/01/2007 | US20070048282 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin |
| 03/01/2007 | US20070048281 Vaccination with a synergistic combination of a Hepatitis C Virus E1 vaccine and an antiviral agent, such as an interferon; improved immunostimulation |
| 03/01/2007 | US20070048277 Homogeneous preparations of il-28 and il-29 |
| 03/01/2007 | US20070048276 Homogeneous preparations of il-28 and il-29 |
| 03/01/2007 | US20070048275 Hepatitis C; antiviral polypeptide |
| 03/01/2007 | US20070048274 Homogeneous preparations of IL-28 and IL-29 |
| 03/01/2007 | US20070048273 Methods of treating cancer using IL-21 |